688426 康为世纪
已收盘 09-15 15:00:00
资讯
新帖
简况
股市必读：康为世纪新发布《2026年第三次临时股东会决议公告》
证券之星 · 09-14 04:08
股市必读：康为世纪新发布《2026年第三次临时股东会决议公告》
每周股票复盘：康为世纪（688426）推2026年限制性股票激励计划
证券之星 · 09-13 03:49
每周股票复盘：康为世纪（688426）推2026年限制性股票激励计划
股市必读：康为世纪新发布《2026年第三次临时股东会决议公告》
证券之星 · 09-11
股市必读：康为世纪新发布《2026年第三次临时股东会决议公告》
康为世纪（688426）披露2026年限制性股票激励计划草案，9月10日股价下跌2.14%
证券之星 · 09-10
康为世纪（688426）披露2026年限制性股票激励计划草案，9月10日股价下跌2.14%
每周股票复盘：康为世纪（688426）董事会人事变动及激励计划进展
证券之星 · 09-06
每周股票复盘：康为世纪（688426）董事会人事变动及激励计划进展
股市必读：康为世纪新发布《关于召开2026年半年度业绩说明会的公告》
证券之星 · 09-03
股市必读：康为世纪新发布《关于召开2026年半年度业绩说明会的公告》
股市必读：康为世纪新发布《第二届董事会第二十五次会议决议公告》
证券之星 · 09-02
股市必读：康为世纪新发布《第二届董事会第二十五次会议决议公告》
股市必读：康为世纪新发布《第二届董事会第二十五次会议决议公告》
证券之星 · 09-01
股市必读：康为世纪新发布《第二届董事会第二十五次会议决议公告》
康为世纪（688426）披露2026年限制性股票激励计划内幕信息知情人买卖公司股票自查报告，8月31日股价上涨1.2%
证券之星 · 08-31
康为世纪（688426）披露2026年限制性股票激励计划内幕信息知情人买卖公司股票自查报告，8月31日股价上涨1.2%
康为世纪（688426）披露2026年半年度报告，8月27日股价下跌2.18%
证券之星 · 08-27
康为世纪（688426）披露2026年半年度报告，8月27日股价下跌2.18%
图解康为世纪中报：第二季度单季净利润同比增长40.20%
证券之星 · 08-27
图解康为世纪中报：第二季度单季净利润同比增长40.20%
康为世纪(688426.SH)发布半年度业绩，归母净亏损3518万元
智通财经 · 08-27
康为世纪(688426.SH)发布半年度业绩，归母净亏损3518万元
每周股票复盘：康为世纪（688426）获肺炎支原体检测试剂三类证
证券之星 · 08-23
每周股票复盘：康为世纪（688426）获肺炎支原体检测试剂三类证
康为世纪（688426）披露2026年限制性股票激励计划草案，8月20日股价上涨19.99%
证券之星 · 08-20
康为世纪（688426）披露2026年限制性股票激励计划草案，8月20日股价上涨19.99%
股市必读：康为世纪新发布《关于自愿披露肺炎支原体核酸及耐药突变位点检测试剂盒（荧光PCR法）获得三类医疗器械注册证的公告》
证券之星 · 08-20
股市必读：康为世纪新发布《关于自愿披露肺炎支原体核酸及耐药突变位点检测试剂盒（荧光PCR法）获得三类医疗器械注册证的公告》
康为世纪最新公告：子公司肺炎支原体检测试剂盒获三类医疗器械注册证
证券之星 · 08-18
康为世纪最新公告：子公司肺炎支原体检测试剂盒获三类医疗器械注册证
每周股票复盘：康为世纪（688426）股东大会通过超募资金补流议案
证券之星 · 07-05
每周股票复盘：康为世纪（688426）股东大会通过超募资金补流议案
每周股票复盘：康为世纪（688426）拟用4500万超募资金补流
证券之星 · 06-20
每周股票复盘：康为世纪（688426）拟用4500万超募资金补流
康为世纪（688426）披露拟使用4500万元超募资金永久补充流动资金，6月16日股价上涨0.73%
证券之星 · 06-16
康为世纪（688426）披露拟使用4500万元超募资金永久补充流动资金，6月16日股价上涨0.73%
股市必读：康为世纪（688426）今年截至6月2日累计跌幅已超25%
证券之星 · 06-03
股市必读：康为世纪（688426）今年截至6月2日累计跌幅已超25%
加载更多
公司概况
公司名称：
江苏康为世纪生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2022-10-25
主营业务：
江苏康为世纪生物科技股份有限公司的主营业务是分子检测底层核心技术的自主研发。公司的主要产品是分子检测原料酶、核酸保存试剂、核酸提取纯化试剂、创新型分子诊断试剂盒、微生物绝对定量、癌症早筛、遗传病检测、抗衰老检测、全质粒测序。
发行价格：
48.98
{"stockData":{"symbol":"688426","market":"SH","secType":"STK","nameCN":"康为世纪","latestPrice":20.2,"timestamp":1789455600000,"preClose":20.85,"halted":0,"volume":706279,"delay":0,"changeRate":-0.0312,"floatShares":112000000,"shares":112000000,"eps":-0.7706,"marketStatus":"已收盘","change":-0.65,"latestTime":"09-15 15:00:00","open":21.19,"high":21.19,"low":20.2,"amount":14466300,"amplitude":0.0475,"askPrice":20.22,"askSize":6,"bidPrice":20.2,"bidSize":45,"shortable":0,"etf":0,"ttmEps":-0.7706,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789522200000},"marketStatusCode":5,"adr":0,"adjPreClose":20.85,"symbolType":"stock_kcb","openAndCloseTimeList":[[1789435800000,1789443000000],[1789448400000,1789455600000]],"highLimit":22.94,"lowLimit":18.77,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":112493716,"isCdr":false,"pbRate":1.72,"roa":"--","roe":"--","epsLYR":-0.977,"committee":0.47541,"marketValue":2272000000,"turnoverRate":0.0063,"status":1,"afterMarket":{"amount":0,"volume":0,"close":20.2,"buyVolume":0,"sellVolume":0,"time":1789457637746,"indexStatus":"已收盘 09-15 15:30:00","preClose":20.85},"floatMarketCap":2267000000},"requestUrl":"/m/hq/s/688426/","defaultTab":"news","newsList":[{"id":"2667863820","title":"股市必读：康为世纪新发布《2026年第三次临时股东会决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2667863820","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667863820?lang=zh_cn&edition=full","pubTime":"2026-09-14 04:08","pubTimestamp":1789330094,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，康为世纪报收于20.37元，下跌1.02%，换手率1.29%，成交量1.45万手，成交额2974.97万元。上海市通力律师事务所关于江苏康为世纪生物科技股份有限公司2026年第三次临时股东会的法律意见书上海市通力律师事务所就康为世纪2026年第三次临时股东会出具法律意见书，确认会议由董事会召集，采取现场与网络投票相结合方式召开；审议通过上述三项议案；表决结果合法有效，出席人员资格及召集人资格符合规定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400001798.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667450021","title":"每周股票复盘：康为世纪（688426）推2026年限制性股票激励计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2667450021","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667450021?lang=zh_cn&edition=full","pubTime":"2026-09-13 03:49","pubTimestamp":1789242549,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，康为世纪报收于20.37元，较上周的21.0元下跌3.0%。本周，康为世纪9月9日盘中最高价报21.79元。本周关注点公司公告汇总：康为世纪召开2026年第三次临时股东会，审议通过2026年限制性股票激励计划相关议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300001424.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666196518","title":"股市必读：康为世纪新发布《2026年第三次临时股东会决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2666196518","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666196518?lang=zh_cn&edition=full","pubTime":"2026-09-11 03:13","pubTimestamp":1789067590,"startTime":"0","endTime":"0","summary":"公司公告汇总：康为世纪于2026年9月10日召开第三次临时股东会，审议通过2026年限制性股票激励计划相关三项议案，均获出席会议股东所持表决权2/3以上通过。上海市通力律师事务所关于江苏康为世纪生物科技股份有限公司2026年第三次临时股东会的法律意见书上海市通力律师事务所就江苏康为世纪生物科技股份有限公司2026年第三次临时股东会出具法律意见书。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100003102.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666550594","title":"康为世纪（688426）披露2026年限制性股票激励计划草案，9月10日股价下跌2.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666550594","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666550594?lang=zh_cn&edition=full","pubTime":"2026-09-10 22:47","pubTimestamp":1789051631,"startTime":"0","endTime":"0","summary":"截至2026年9月10日收盘，康为世纪报收于20.58元，较前一交易日下跌2.14%，最新总市值为23.15亿元。该股当日开盘20.95元，最高21.21元，最低20.51元，成交额达1757.87万元，换手率为0.75%。三项议案均为特别决议议案，已获出席会议股东所持表决权的2/3以上通过。激励对象及其关联方未参与表决。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000042645.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665366666","title":"每周股票复盘：康为世纪（688426）董事会人事变动及激励计划进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2665366666","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665366666?lang=zh_cn&edition=full","pubTime":"2026-09-06 03:36","pubTimestamp":1788636972,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，康为世纪报收于21.0元，较上周的20.77元上涨1.11%。本周，康为世纪9月2日盘中最高价报21.82元。公司公告汇总：2026年限制性股票激励计划激励对象名单公示期无异议，符合规定条件。公司于2026年8月21日至8月31日对2026年限制性股票激励计划拟激励对象的姓名和职务进行了内部公示，公示期间未收到异议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600001229.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664846897","title":"股市必读：康为世纪新发布《关于召开2026年半年度业绩说明会的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664846897","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664846897?lang=zh_cn&edition=full","pubTime":"2026-09-03 02:39","pubTimestamp":1788374350,"startTime":"0","endTime":"0","summary":"截至2026年9月2日收盘，康为世纪报收于21.47元，上涨0.99%，换手率1.89%，成交量2.12万手，成交额4558.78万元。公司公告汇总：康为世纪将于9月9日16:00-17:00通过上证路演中心召开2026年半年度业绩说明会，董事长兼总经理王春香博士、董事会秘书谢俊先生将出席。投资者可于2026年9月3日至9月8日中午12:00前通过上证路演中心网站或公司邮箱IRM@cwbio.cn提交问题。说明会后可通过该平台查看会议内容。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300002252.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664865669","title":"股市必读：康为世纪新发布《第二届董事会第二十五次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664865669","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664865669?lang=zh_cn&edition=full","pubTime":"2026-09-02 02:31","pubTimestamp":1788287469,"startTime":"0","endTime":"0","summary":"关于聘任公司内部审计负责人的公告江苏康为世纪生物科技股份有限公司于2026年8月31日召开第二届董事会第二十五次会议，审议通过聘任李斌先生为公司内部审计负责人，任期自董事会审议通过之日起至第二届董事会届满为止。董事会薪酬与考核委员会关于公司2026年限制性股票激励计划授予激励对象名单的核查意见及公示情况说明公司于2026年8月20日召开第二届董事会第二十四次会议，审议通过《2026年限制性股票激励计划（草案）》及其摘要。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200002430.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664008990","title":"股市必读：康为世纪新发布《第二届董事会第二十五次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664008990","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664008990?lang=zh_cn&edition=full","pubTime":"2026-09-01 02:12","pubTimestamp":1788199934,"startTime":"0","endTime":"0","summary":"公司公告汇总第二届董事会第二十五次会议决议公告江苏康为世纪生物科技股份有限公司于2026年8月31日召开第二届董事会第二十五次会议，审议通过《关于聘任董事会秘书的议案》和《关于聘任公司内部审计负责人的议案》，同意聘任谢俊为董事会秘书、李斌为内部审计负责人，任期均至第二届董事会届满；两人均未持有公司股票，与主要股东及高管无关联关系；原董事会秘书戚玉柏已于2026年8月28日辞去职务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100002290.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663039074","title":"康为世纪（688426）披露2026年限制性股票激励计划内幕信息知情人买卖公司股票自查报告，8月31日股价上涨1.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663039074","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663039074?lang=zh_cn&edition=full","pubTime":"2026-08-31 18:29","pubTimestamp":1788172163,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘，康为世纪报收于21.02元，较前一交易日上涨1.2%，最新总市值为23.65亿元。该股当日开盘20.46元，最高21.43元，最低20.35元，成交额达4817.32万元，换手率为2.04%。公司于近日披露《关于2026年限制性股票激励计划内幕信息知情人买卖公司股票情况的自查报告》。公告显示，江苏康为世纪生物科技股份有限公司于2026年8月20日召开第二届董事会第二十四次会议，审议通过《2026年限制性股票激励计划（草案）》及其摘要，并于8月21日披露相关公告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100028334.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662701104","title":"康为世纪（688426）披露2026年半年度报告，8月27日股价下跌2.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662701104","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662701104?lang=zh_cn&edition=full","pubTime":"2026-08-27 19:27","pubTimestamp":1787830032,"startTime":"0","endTime":"0","summary":"截至2026年8月27日收盘，康为世纪报收于21.11元，较前一交易日下跌2.18%，最新总市值为23.75亿元。该股当日开盘21.33元，最高21.65元，最低21.0元，成交额达3514.08万元，换手率为1.48%。近日，江苏康为世纪生物科技股份有限公司召开第二届董事会第二十三次会议，审议通过《2026年半年度报告》及其摘要、《2026年半年度募集资金存放、管理与实际使用情况的专项报告》及《2026年度提质增效重回报专项行动方案的半年度评估报告》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700045858.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662370936","title":"图解康为世纪中报：第二季度单季净利润同比增长40.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662370936","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662370936?lang=zh_cn&edition=full","pubTime":"2026-08-27 18:58","pubTimestamp":1787828296,"startTime":"0","endTime":"0","summary":"证券之星消息，康为世纪2026年中报显示，上半年度公司主营收入1.13亿元，同比上升29.73%；归母净利润-3518.49万元，同比上升37.07%；扣非净利润-4538.54万元，同比上升31.81%；其中2026年第二季度，公司单季度主营收入5402.25万元，同比上升22.46%；单季度归母净利润-1983.28万元，同比上升40.2%；单季度扣非净利润-2480.44万元，同比上升34.36%；负债率10.83%，投资收益299.86万元，财务费用121.34万元，毛利率48.81%。财报数据概要请见下图:本文数据来源于康为世纪2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700045135.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662720687","title":"康为世纪(688426.SH)发布半年度业绩，归母净亏损3518万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2662720687","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662720687?lang=zh_cn&edition=full","pubTime":"2026-08-27 17:13","pubTimestamp":1787822023,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康为世纪(688426.SH)披露2026年半年度报告，报告期公司实现营业收入1.13亿元，同比增长29.73%;归属于上市公司股东的净利润亏损3518万元，同比收窄;归属于上市公司股东的扣除非经常性损益的净利润亏损4539万元，同比收窄;基本每股收益-0.320元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1486981.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"康为世纪(688426.SH)发布半年度业绩，归母净亏损3518万元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661114312","title":"每周股票复盘：康为世纪（688426）获肺炎支原体检测试剂三类证","url":"https://stock-news.laohu8.com/highlight/detail?id=2661114312","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661114312?lang=zh_cn&edition=full","pubTime":"2026-08-23 02:18","pubTimestamp":1787422692,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，康为世纪报收于22.42元，较上周的19.12元上涨17.26%。本周，康为世纪8月21日盘中最高价报23.39元。本周关注点公司公告汇总：肺炎支原体核酸及耐药突变位点检测试剂盒获Ⅲ类医疗器械注册证。本次获批进一步丰富了公司呼吸道病原体检测试剂产品管线，对公司未来经营发展具有积极影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082300000402.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660428002","title":"康为世纪（688426）披露2026年限制性股票激励计划草案，8月20日股价上涨19.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660428002","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660428002?lang=zh_cn&edition=full","pubTime":"2026-08-20 22:12","pubTimestamp":1787235139,"startTime":"0","endTime":"0","summary":"截至2026年8月20日收盘，康为世纪报收于22.87元，较前一交易日上涨19.99%，最新总市值为25.73亿元。该股当日开盘20.5元，最高22.87元，最低20.09元，成交额达4776.78万元，换手率为1.9%。近日，康为世纪发布《关于召开2026年第三次临时股东会的通知》，拟于2026年9月10日召开2026年第三次临时股东会，审议《2026年限制性股票激励计划（草案）》及其摘要、实施考核管理办法、授权董事会办理相关事宜等三项议案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000045016.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660478849","title":"股市必读：康为世纪新发布《关于自愿披露肺炎支原体核酸及耐药突变位点检测试剂盒（荧光PCR法）获得三类医疗器械注册证的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2660478849","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660478849?lang=zh_cn&edition=full","pubTime":"2026-08-20 03:14","pubTimestamp":1787166852,"startTime":"0","endTime":"0","summary":"截至2026年8月19日收盘，康为世纪报收于19.06元，下跌1.35%，换手率1.04%，成交量1.16万手，成交额2232.79万元。公司公告汇总：全资子公司自主研发的肺炎支原体核酸及耐药突变位点检测试剂盒获国家药监局Ⅲ类医疗器械注册证，注册证编号国械注准20263401716，有效期至2031年8月16日。该产品用于体外定性检测人咽拭子样本中肺炎支原体DNA及其23S rRNA2063和2064耐药突变位点，可同步实现感染检测与耐药信息判读，辅助临床合理用药。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000002762.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","09996","BK1583","159883","BK0239","BK1100","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660464571","title":"康为世纪最新公告：子公司肺炎支原体检测试剂盒获三类医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2660464571","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660464571?lang=zh_cn&edition=full","pubTime":"2026-08-18 19:19","pubTimestamp":1787051962,"startTime":"0","endTime":"0","summary":"康为世纪(688426.SH)公告称，公司全资子公司健为诊断自主研发的肺炎支原体核酸及耐药突变位点检测试剂盒(荧光PCR法)获国家药监局颁发的Ⅲ类医疗器械注册证。该产品可同步检测肺炎支原体感染及大环内酯类抗生素耐药突变位点，辅助指导临床合理用药。此次获证是公司在呼吸道疾病检测领域取得的第5张Ⅲ类注册证，进一步丰富产品管线，有望提升公司在呼吸道感染分子诊断市场的竞争力。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800036714.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK1583","BK0239","BK1100","159883","09996","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649924466","title":"每周股票复盘：康为世纪（688426）股东大会通过超募资金补流议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2649924466","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649924466?lang=zh_cn&edition=full","pubTime":"2026-07-05 04:14","pubTimestamp":1783196051,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，康为世纪报收于18.34元，较上周的19.11元下跌4.03%。本周，康为世纪6月29日盘中最高价报19.46元。本周关注点公司公告汇总：股东大会审议通过使用部分超募资金永久补充流动资金的议案，同意股数占比99.9297%。公司公告汇总上海市通力律师事务所就江苏康为世纪生物科技股份有限公司2026年第二次临时股东会的召集召开程序、出席人员资格、表决程序及表决结果出具法律意见。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500001491.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644206630","title":"每周股票复盘：康为世纪（688426）拟用4500万超募资金补流","url":"https://stock-news.laohu8.com/highlight/detail?id=2644206630","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644206630?lang=zh_cn&edition=full","pubTime":"2026-06-20 03:42","pubTimestamp":1781898134,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，康为世纪报收于16.32元，较上周的16.88元下跌3.32%。本周，康为世纪6月15日盘中最高价报17.25元。6月18日盘中最低价报15.83元，股价触及近一年最低点。康为世纪当前最新总市值18.36亿元，在医疗器械板块市值排名125/129，在两市A股市值排名5081/5206。本周关注点公司公告汇总：康为世纪拟使用超募资金4,500.00万元永久补充流动资金。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062000002167.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643759371","title":"康为世纪（688426）披露拟使用4500万元超募资金永久补充流动资金，6月16日股价上涨0.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2643759371","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2643759371?lang=zh_cn&edition=full","pubTime":"2026-06-16 18:49","pubTimestamp":1781606951,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘，康为世纪报收于16.5元，较前一交易日上涨0.73%，最新总市值为18.56亿元。该股当日开盘16.37元，最高16.65元，最低15.9元，成交额达1627.36万元，换手率为0.89%。近日，江苏康为世纪生物科技股份有限公司披露《2026年第二次临时股东会会议资料》，公告显示公司拟使用超募资金4,500.00万元永久补充流动资金，占超募资金总额15,508.19万元的29.02%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600036619.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640253729","title":"股市必读：康为世纪（688426）今年截至6月2日累计跌幅已超25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640253729","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640253729?lang=zh_cn&edition=full","pubTime":"2026-06-03 04:18","pubTimestamp":1780431492,"startTime":"0","endTime":"0","summary":"截至2026年6月2日收盘，康为世纪报收于18.18元，下跌4.27%，换手率1.01%，成交量1.13万手，成交额2085.45万元。交易信息汇总股价提醒6月2日康为世纪收盘报18.18元，跌4.27%，当日成交2085.45万元。该股已连续7日下跌，当年累计跌幅27.48%。前10个交易日中，主力资金累计净流出507.18万元，股价累计下跌18.95%；融资余额累计增加70.75万元，融券余量累计增加0股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300006503.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789474695791,"stockEarnings":[{"period":"1week","weight":-0.0188},{"period":"1month","weight":0.0905},{"period":"3month","weight":0.2636},{"period":"6month","weight":-0.0799},{"period":"1year","weight":-0.3057},{"period":"ytd","weight":-0.1251}],"compareEarnings":[{"period":"1week","weight":-0.012},{"period":"1month","weight":-0.0107},{"period":"3month","weight":-0.0505},{"period":"6month","weight":-0.0437},{"period":"1year","weight":0.0038},{"period":"ytd","weight":-0.021}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江苏康为世纪生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"4610人(较上一季度增加4.63%)","perCapita":"24344股","listingDate":"2022-10-25","address":"江苏省泰州市海陵区医药高新区泽兰路18号","registeredCapital":"11249万元","survey":" 江苏康为世纪生物科技股份有限公司的主营业务是分子检测底层核心技术的自主研发。公司的主要产品是分子检测原料酶、核酸保存试剂、核酸提取纯化试剂、创新型分子诊断试剂盒、微生物绝对定量、癌症早筛、遗传病检测、抗衰老检测、全质粒测序。","listedPrice":48.98},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康为世纪(688426)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康为世纪(688426)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康为世纪,688426,康为世纪股票,康为世纪股票老虎,康为世纪股票老虎国际,康为世纪行情,康为世纪股票行情,康为世纪股价,康为世纪股市,康为世纪股票价格,康为世纪股票交易,康为世纪股票购买,康为世纪股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康为世纪(688426)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康为世纪(688426)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}